Neurodegenerative diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and idiopathic normal pressure hydrocephalus (iNPH), are characterised by the progressive loss of neuronal function and structure, leading to severe cognitive and motor impairments. Due to their progressive nature and the lack of effective curative treatments, these diseases pose significant challenges to global healthcare systems [1,2].. Understanding the underlying mechanisms of these diseases is crucial fo…